Insufficient scRNA-seq data for expression of F2RL2 at single-cell level.
Insufficient scRNA-seq data for expression of F2RL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 98% | 401.14 | 946 / 966 | 73% | 8.56 | 385 / 527 |
esophagus | 86% | 379.54 | 1237 / 1445 | 82% | 16.91 | 150 / 183 |
breast | 69% | 313.88 | 319 / 459 | 88% | 33.82 | 982 / 1118 |
stomach | 74% | 172.80 | 264 / 359 | 84% | 15.03 | 239 / 286 |
pancreas | 60% | 69.28 | 197 / 328 | 85% | 17.62 | 151 / 178 |
skin | 94% | 302.09 | 1696 / 1809 | 44% | 16.29 | 207 / 472 |
uterus | 85% | 180.03 | 145 / 170 | 32% | 2.98 | 146 / 459 |
lung | 61% | 76.62 | 350 / 578 | 39% | 9.02 | 447 / 1155 |
bladder | 52% | 72.57 | 11 / 21 | 32% | 5.13 | 159 / 504 |
blood vessel | 75% | 134.66 | 995 / 1335 | 0% | 0 | 0 / 0 |
prostate | 51% | 50.29 | 124 / 245 | 18% | 0.94 | 90 / 502 |
tonsil | 0% | 0 | 0 / 0 | 64% | 8.25 | 29 / 45 |
liver | 50% | 53.00 | 112 / 226 | 11% | 0.95 | 43 / 406 |
heart | 50% | 56.87 | 430 / 861 | 0% | 0 | 0 / 0 |
kidney | 34% | 33.87 | 30 / 89 | 16% | 1.46 | 144 / 901 |
thymus | 33% | 30.20 | 216 / 653 | 15% | 0.94 | 88 / 605 |
adrenal gland | 40% | 36.55 | 102 / 258 | 7% | 1.92 | 15 / 230 |
brain | 15% | 43.81 | 409 / 2642 | 18% | 2.22 | 130 / 705 |
adipose | 23% | 30.90 | 279 / 1204 | 0% | 0 | 0 / 0 |
spleen | 19% | 11.81 | 45 / 241 | 0% | 0 | 0 / 0 |
ovary | 6% | 5.37 | 10 / 180 | 9% | 0.67 | 37 / 430 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.11 | 1 / 29 |
muscle | 3% | 4.16 | 25 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 2.48 | 28 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.05 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1990806 | Biological process | ligand-gated ion channel signaling pathway |
GO_0035025 | Biological process | positive regulation of Rho protein signal transduction |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0007596 | Biological process | blood coagulation |
GO_0070493 | Biological process | thrombin-activated receptor signaling pathway |
GO_0009611 | Biological process | response to wounding |
GO_0030168 | Biological process | platelet activation |
GO_0032024 | Biological process | positive regulation of insulin secretion |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0015057 | Molecular function | thrombin-activated receptor activity |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0048018 | Molecular function | receptor ligand activity |
GO_0004435 | Molecular function | phosphatidylinositol phospholipase C activity |
Gene name | F2RL2 |
Protein name | F2RL2 protein Proteinase-activated receptor 3 (PAR-3) (Coagulation factor II receptor-like 2) (Thrombin receptor-like 2) |
Synonyms | PAR3 |
Description | FUNCTION: Receptor for activated thrombin coupled to G proteins that stimulate phosphoinositide hydrolysis. . |
Accessions | ENST00000296641.5 [O00254-1] O00254 Q4VBN6 ENST00000504899.1 [O00254-2] |